Aldeyra Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
2.21
0.03
(1.38%)
Volume:
1,161,025
52 week range:
1.14 - 7.20
Market Cap:
131.956M
Company Description:
Aldeyra Therapeutics, Inc. develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for dry eye diseases and allergic conjunctivitis.